SH3RF2
Basic information
Region (hg38): 5:145936578-146081791
Previous symbols: [ "PPP1R39" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (114 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SH3RF2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000152550.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 109 | 113 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 112 | 4 | 0 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SH3RF2 | protein_coding | protein_coding | ENST00000511217 | 9 | 145213 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.27e-13 | 0.164 | 125614 | 0 | 134 | 125748 | 0.000533 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.124 | 448 | 441 | 1.02 | 0.0000268 | 4704 |
Missense in Polyphen | 145 | 135.89 | 1.067 | 1494 | ||
Synonymous | -0.997 | 209 | 191 | 1.09 | 0.0000124 | 1577 |
Loss of Function | 0.941 | 23 | 28.4 | 0.810 | 0.00000163 | 311 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000994 | 0.000993 |
Ashkenazi Jewish | 0.000201 | 0.000198 |
East Asian | 0.000223 | 0.000217 |
Finnish | 0.000323 | 0.000323 |
European (Non-Finnish) | 0.000653 | 0.000651 |
Middle Eastern | 0.000223 | 0.000217 |
South Asian | 0.000721 | 0.000719 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Has E3 ubiquitin-protein ligase activity (PubMed:24130170). Acts as an anti-apoptotic regulator of the JNK pathway by ubiquitinating and promoting the degradation of SH3RF1, a scaffold protein that is required for pro-apoptotic JNK activation (PubMed:22128169). Facilitates TNF-alpha-mediated recruitment of adapter proteins TRADD and RIPK1 to TNFRSF1A and regulates PAK4 protein stability via inhibition of its ubiquitin- mediated proteasomal degradation (PubMed:24130170). Inhibits PPP1CA phosphatase activity (PubMed:19945436, PubMed:19389623). {ECO:0000269|PubMed:19389623, ECO:0000269|PubMed:19945436, ECO:0000269|PubMed:22128169, ECO:0000269|PubMed:24130170}.;
Recessive Scores
- pRec
- 0.0978
Intolerance Scores
- loftool
- 0.554
- rvis_EVS
- -0.15
- rvis_percentile_EVS
- 42.32
Haploinsufficiency Scores
- pHI
- 0.179
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.475
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.513
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sh3rf2
- Phenotype
Gene ontology
- Biological process
- negative regulation of phosphatase activity;positive regulation of cell migration;negative regulation of protein ubiquitination;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;negative regulation of phosphoprotein phosphatase activity;negative regulation of apoptotic process;negative regulation of JNK cascade;positive regulation of JNK cascade;protein autoubiquitination
- Cellular component
- nucleus;nucleoplasm
- Molecular function
- protein phosphatase inhibitor activity;protein binding;protein phosphatase 1 binding;phosphatase binding;metal ion binding;ubiquitin protein ligase activity